---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-25-060467"
form_type: "8-K"
ticker: "HSCS"
cik: "0001468492"
company_name: "HeartSciences Inc."
filed_at: "2025-07-01T23:59:59+00:00"
generated_at: "2026-05-18T09:56:39.706112+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.15
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# HeartSciences amends bylaws to add jury waiver, 3% derivative threshold

## Summary
- Adds jury trial waiver for 'internal entity claims' under Texas Business Organizations Code.
- Requires 3% ownership threshold for shareholders to initiate derivative proceedings.
- Technical revisions to clarify exclusive forum provision.
- Amendments effective June 27, 2025, filed as Exhibit 3.1.

## SEC filing metadata
- accession: 0001213900-25-060467
- form_type: 8-K
- ticker: HSCS
- cik: 0001468492
- company_name: HeartSciences Inc.
- filed_at: 2025-07-01T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.15
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1468492/000121390025060467/0001213900-25-060467-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1468492/000121390025060467/ea0247855-8k_heart.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-25-060467
- JSON: https://secwatch.observer/filing/0001213900-25-060467.json
- Plain text: https://secwatch.observer/filing/0001213900-25-060467.txt

## Key facts
- Governance Changes
  HeartSciences Inc.: Amended Bylaws to add jury trial waiver for internal entity claims, adopt ownership threshold for derivative proceedings, and clarify exclusive forum provision (effective 2025-06-27).
  - Change: bylaw amendment
  - Effective: 2025-06-27
  source text: On June 27, 2025, in connection with certain recent changes to the Texas Business Organizations Code (“TBOC”) and in light of Texas law, the Board of Directors of HeartSciences Inc. (the “Company”) adopted certain amendments to the Company’s Bylaws (the “Bylaws”) in order to: (i) add a new section to provide for a jury trial waiver for “internal entity claims” as defined in the TBOC; (ii) add a new section to adopt an ownership threshold requiring any shareholder or group of shareholders to hold shares of common stock sufficient to meet an ownership threshold of at least 3% of the Company’s issued and outstanding shares in order to institute or maintain a derivative proceeding; and (iii) make technical revisions to clarify the scope of the exclusive forum provision.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1468492/000121390025060467/0001213900-25-060467-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.